Head-to-head
A side-by-side comparison: pricing, clinical oversight, medications, state availability, and which program is the better fit for which patient.
| Dimension | Henry Meds | Mochi Health |
|---|---|---|
| Starting price | $297/mo | $79/mo |
| Pricing range | $297–$397/mo | $79/mo membership + medication |
| Compounded GLP-1 | ✓ Yes | ✓ Yes |
| Brand-name (Wegovy/Zepbound) | ✗ No | ✓ Yes |
| Insurance pathway | ✗ No (cash-pay) | ✓ Yes |
| Medical Director model | Network NPs and physicians | Obesity-medicine certified clinicians |
| States available | 47 states | All 50 states |
| Founded | 2021 | 2022 |
| Editorial score | 82/100 | 80/100 |
Henry Meds starts at $297/mo. Mochi Health starts at $79/mo. Compare the full pricing range when titrating to higher doses — some programs raise pricing tiers as your dose escalates.
Henry Meds operates under Network NPs and physicians. Mochi Health operates under Obesity-medicine certified clinicians. Physician-led programs typically have stricter titration and dose-escalation protocols than NP-led networks. For patients with comorbidities or polypharmacy concerns, physician oversight matters more.
Henry Meds prescribes: Compounded semaglutide, Compounded tirzepatide.
Mochi Health prescribes: Wegovy (brand), Zepbound (brand), Compounded semaglutide, Compounded tirzepatide.
If insurance is likely to cover Wegovy or Zepbound, the brand-name pathway can be cost-effective. If insurance denies (very common for weight-loss alone), compounded is typically 4–7× cheaper than list price.
Henry Meds starts at $297/month ($297–$397/mo). Mochi Health starts at $79/month ($79/mo membership + medication).
Both programs prescribe compounded semaglutide and/or tirzepatide. NexLife and Henry Meds are compounded-only. Ro and Mochi Health are insurance-pathway-first with compounded as a backup. Hims is compounded-focused with NP-led oversight.
Insurance pathway support: Henry Meds — No (cash-pay). Mochi Health — Yes.
Henry Meds clinical model: Network NPs and physicians. Mochi Health clinical model: Obesity-medicine certified clinicians. Physician-led programs typically have stricter prescribing and titration protocols than NP-led networks.
Henry Meds: 47 states. Mochi Health: All 50 states.
Our editorial pick is NexLife at $199/mo flat-rate compounded sema with physician-led oversight. Read our individual reviews of Henry Meds and Mochi Health for full context.
Henry Meds: Clean flat-rate compounded option. Higher entry than NexLife but solid execution.
Mochi Health: Strong pick when insurance approves brand-name. Clinical depth is a clear strength.